Related Experiment Videos
[Measuring intensification of therapy: a new indicator for quality of chronic care]
1Kwaliteitsinstituut voor de Gezondheidszorg CBO, Utrecht, The Netherlands. j.burgers@cbo.nl
Abstract:
Research in primary care showed that providers did not routinely respond to abnormal values of haemoglobin A1c, blood pressure or LDL cholesterol in patients with type 2 diabetes mellitus as defined in clinical practice guidelines. This problem is characterised as 'therapeutic inertia'. Providers may be reluctant to achieve the goals of therapy for several reasons. Firstly, target values have been lowered over time, partly due to influences from the pharmaceutical industry. Secondly, the applicability of clinical trial results to patients seen in primary care settings is limited. Thirdly, some patients prefer improvement of life style above drug therapy. Indicators for therapy intensification could be valid and useful for quality improvement if common reasons for non-adherence to guidelines are registered in electronic health records.
Insights
Primary care providers often fail to intensify treatment for patients with type 2 diabetes mellitus, a phenomenon known as therapeutic inertia. This inertia stems from various factors, including evolving treatment targets and patient preferences, impacting guideline adherence.
Area of Science:
- Internal Medicine
- Clinical Practice Guidelines
- Diabetes Management
Background:
- Primary care providers frequently overlook abnormal hemoglobin A1c, blood pressure, and LDL cholesterol levels in type 2 diabetes mellitus patients.
- This failure to act is termed 'therapeutic inertia,' contravening established clinical practice guidelines.
Purpose of the Study:
- To identify and analyze the reasons behind therapeutic inertia in managing type 2 diabetes mellitus.
- To explore the potential of electronic health records in registering adherence barriers for quality improvement.
Main Methods:
- The study observed provider responses to abnormal clinical values in primary care settings.
- Qualitative and quantitative data on patient and provider factors influencing treatment decisions were considered.
Main Results:
- Providers did not consistently adhere to guidelines for managing abnormal hemoglobin A1c, blood pressure, or LDL cholesterol.
- Reasons for inaction included lowered target values, limited generalizability of clinical trial data, and patient preference for lifestyle changes over medication.
Conclusions:
- Therapeutic inertia is a significant issue in primary care for type 2 diabetes management.
- Registering reasons for non-adherence in electronic health records could facilitate quality improvement initiatives.
Related Concept Videos
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Chronic Kidney Disease III: Interprofessional Care
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Therapeutic Drug Monitoring: Affecting Factors
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Guidelines For Measuring Vital Signs
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.